haloperidol has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chadchankar, H; Yavich, L | 1 |
| Alhakamy, NA; Anwer, MK; Bhattamisra, SK; Choudhury, H; Lim, WM; Md, S; Radhakrishnan, AK; Safian, NH; Shahzad, N; Shak, AT; Xi, LW | 1 |
| Adekunle, AO; Alananzeh, WA; Amali, MO; Ayipo, YO; Badeggi, UM; Lawal, BA; Mordi, MN | 1 |
3 other study(ies) available for haloperidol and alpha-synuclein
| Article | Year |
|---|---|
Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Biophysical Phenomena; Biophysics; Blood Proteins; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electric Stimulation; Haloperidol; Male; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neuronal Plasticity; Piperazines; Time Factors | 2011 |
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
Topics: Administration, Intranasal; alpha-Synuclein; Animals; Blood-Brain Barrier; Cell Line, Tumor; Chitosan; Disease Models, Animal; Dopamine Agonists; Drug Carriers; Female; Haloperidol; Humans; Male; Nanoparticles; Neurons; Oxidopamine; Parkinson Disease, Secondary; Particle Size; Rats; Tetrahydronaphthalenes; Thiophenes; Toxicity Tests, Acute | 2020 |
Phytoconstituents of Datura metel extract improved motor coordination in haloperidol-induced cataleptic mice: Dual-target molecular docking and behavioural studies.
Topics: alpha-Synuclein; Animals; Antioxidants; Antiparkinson Agents; Atropine Derivatives; Carbidopa; Cholinergic Antagonists; Datura metel; Dopa Decarboxylase; Haloperidol; Levodopa; Methanol; Mice; Molecular Docking Simulation; Parkinson Disease; Phytochemicals; Plant Extracts; Scopolamine | 2023 |